Drug intelligence / Profile preview

MYCOLOCK Plus

Development stage: Unknown
Lead developer: Pepco
Modality: Small Molecules
Administration: Oral

Overview

MYCOLOCK Plus is a veterinary feed safety additive developed by Pepco Pharma, specifically formulated as a mycotoxin binder for use in poultry, dairy, and livestock feed. It is designed to mitigate the harmful effects of mycotoxin contamination, which can lead to reduced performance, immunosuppression, and various health issues in animals. The product works by sequestering or neutralizing mycotoxins in the gut, preventing their systemic absorption. It is administered orally, typically incorporated directly into animal feed or premixes.

Brand names: MYCOLOCK Plus

Beyond the preview

Go deeper on MYCOLOCK Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYCOLOCK Plus.

Explore the full profile